… in 11,558 hospitalized patients that … , open-label, randomized controlled trial designed to
assess the effectiveness and safety of COVID-19 convalescent plasma in hospitalized patients. …

… We conducted a prospective, randomized, open-label, multicenter trial of favipiravir for the
treatment of COVID-19 at 25 hospitals across Japan. Eligible patients were adolescents and …

… patients receiving a 10-day course of dexamethasone among hospitalized patients with severe
COVID-19 (patients … short course of MP only in patients over 60 years with severe COVID …

… of tocilizumab in adult patients admitted to hospital with COVID-19 with … hospital discharge
and successful cessation of invasive mechanical ventilation, with patients who died in hospital …

… Thromboprophylaxis with low molecular weight heparin in hospitalized patients with COVID-19
… an open-label, multicenter, randomized, controlled trial in adult patients hospitalized with …

… in hospital mortality, similar to the study by Rivers and colleagues (19), with a two-sided α of
0.05, a power of 80%, and to allow for a 20-patient … in hospitalized patients with acute heart …

… of antiviral monoclonal antibody therapy in patients admitted to hospital with COVID-19. We
found that in 3153 COVID-19 patients admitted to hospital without detectable antibodies to …

… We aimed to evaluate the efficacy and safety of colchicine in patients admitted to hospital …
, the proportion of patients discharged from hospital within 28 days, and, in patients not on …

… We used the same method to analyse time to hospital discharge, with patients who died
in hospital right-censored on day 29 (as for such patients it was known that they were not …

… , open-label, randomized controlled trial and enrolled consecutive patients admitted to our
hospital … Trial sites were three different COVID-19 departments of the University Hospital of …